Macronutrients
Macronutrients have many documented roles in cellular function and thus are critical in the wound healing process. Of nearly any population, athletes generally maintain an adequate diet specifically designed to meet the needs of their sport. Most athletes eat a balanced diet that adequately supplies both macro and macronutrients. Therefore, defects in collagen, elastin and proteoglycan metabolism are generally only seen as a result of deficiencies or excess. As well, successful healing of connective tissue injuries will rely on the presence of adequate nutritional stores.
As voiced in the field of protein balance, is a state of “accommodation” of micronutrient intake satisfactory in wound healing? (1,2) The body adjusts to changes within different ranges of a nutrient intake. In relation to protein, Waterlow (2) stated that “some adaptations may be at the expense of full functional ability.” For instance, a child may survive on an undernourished diet, but with a slower rate of growth and develop into a smaller-sized adult with sub-average muscle mass and physical strength. Such an adjustment has been termed “accommodation” rather than full adaptation with no loss of function (1,3). This then poses the question of the need for pharmacological supplementation of macronutrients during wound healing. During wound healing is there a need for higher than normally recommended levels to obtain micronutrient balance?
There are several ways a micronutrient deficiency can manifest: deficiencies caused by dietary intake, diet-gene interactions, and nutrient-drug interactions. The first is self-explanatory. Secondly, a genetic dysfunction may produce a differential response to a diet that is deficient or marginal in a nutrient. Additional, a single or multiple mutant genes may result in expression which resembles a nutrient deficiency or toxicity. These are clinically seen as genetic disorders resulting in abnormal metabolism of macronutrients. Thirdly, some studies suggest that connective tissue defects result from drug interaction with macronutrients.
Vitamins
Vitamin C
Of all the vitamins, ascorbic acid probably has the most influence on connective tissue metabolism and has been the most studied. The roles of AA in connective tissue can be quite complex and varied. Macromolecule turnover is affected by synthesis and intracellular and extracelluar degradation. Important mediators of these two processes are enzymes. Ascorbic acid is a cofactor for many of the enzymatic reactions in synthetic processes. Degradation of collagen outpaces syntheses; new collagen cannot replace losses and results in disease (scurvy).
In connective tissue, AA is involved in several metabolic reactions. Iron is necessary for a variety of enzymatic reactions, and AA protects iron from oxidation. AA preserves the enzyme-iron complex that catalyzes the reaction for intracellular assembly of collagen (6,35,36). Underhydroxylated collagen is unable to fold into a stable triple-helix and therefore is subject to increased intracellular degradation. The turnover rate of collagen is then in negative balance and degradation outpaces the rate of synthesis.
A large focus of research in AA and connective tissue has been related to the pathophysiology of diabetes. Animal and human diabetics appear to be deficient in plasma concentrations of AA which may be connected to associated delays in wound healing by decreased synthesis of collagen and Pgs (33,36). AA is structurally similar to glucose and its cellular uptake is mediated by glucose transport mechanisms. Studies have shown that cellular uptake of AA is inhibited by high extracellular concentrations of glucose (in the presence of as well as the absence of insulin) as seen in diabetes (4,5,33). This inhibition of AA uptake may exacerbate problems associated with AA deficiencies. Ths, increased intake of dietary AA may prevent inhibition induced by high glucose on collagen and proteoglycan syntheses (4,5).
In addition to collagen, the influence of AA extends to proteoglycans (Pgs). AA may serve as a cofactor in sulfation reactions in PGs (4,6,35), However, the exact mechanism of AA influence in GAG metabolism is not yet elucidated.
The most commonly known role of AA is as an antioxidant. Although not clearly demonstrated in the literature, AA may protect macromolecules from damage by free radicals by acting as a scavenger. These deleterious metabolites are highly reactive by-products produced from metabolism of glucose, one of which is free radicals. Thus, some authors postulate that AA deficiency may intensify oxidative damage leading to secondary effects on cellular structures and functions (5,33,36).
Recommendations for dietary intake of AA remain controversial. The increased demand for collagen synthesis in growing or injured individuals, or in diabetics with low plasma levels may require higher intakes of dietary AA. Studies with animals are difficult to extrapolate to humans as species requirement for AA most likely varies (4). As well, alterations in connective tissue by nutrient or other factors such as pharmaceuticals depend on whether they are of short-term or long-term duration. Age, typ of nutritional alteration, and specific tissue are also factors.
The Recommended Daily Allowance (RDA) for vitamin C was determined by the amount necessary to prevent scurvy and the amount where excess is eliminated from the body. The daily amount believed to prevent scurvy in an adult on a diet deficient in vitamin C is 10 mg./day. Considering depletion and turnover rates of whole body AA, the RDA was arbitrarily set at 60 mg./day for an adult male and female. However, by conventional reasoning, if the body requires higher levels of AA due to higher turnover rates, such as in disease or injury, then higher doses may be warranted and tolerated. Some proponents of increased vitamin C dosages use bowel tolerance to determine the maximum therapeutic dose.
Bowel tolerance is a method to determine body tolerance to AA. Theoretically, the sicker the body is, the more AA the body utilizes and can therefore tolerate higher doses. When plasma, intracellular and extracellular compartments are maximized, whole body tolerance is reached. Excess intake results in increased bowel activity. The levels where such symptoms appear vary individually with physiological status. During illness or injury, an individual may tolerate very high doses and experience no diarrhea. After the sickness or injury, the body does not require high doses and tolerance decreases, causing diarrhea. Many proponents claim that doses just below the bowel tolerance are most therapeutic. However, studies with such therapeutic doses have not been performed with human subjects. Nevertheless, research with animal models has shown that such therapeutic doses of AA resulted in reduced symptoms of osteoarthritis. Also, AA supplementation in surgical and non-surgical patients resulted in improved would healing, reduced inflammation and improved recovery.
Vitamin B Complex
The B vitamin complex is a large group of compounds with different structure and biological activity. They are usually found within the same food sources. The primary role of the B vitamins is cellular energy metabolism. Any deficit in cellular energy will have adverse effects on cellular function. Therefore, the B vitamins are essential in connective tissue metabolism.
Many of the B complex serve as cofactors in the process of collagen and elastin cross-linking. Deficiencies in several of the B vitamins influence expression of collagen genes and induce decreased mechanical strength of repaired and remodeled tissue (32,34,35).
Since most B vitamins are found together in similar food groups, deficiencies of one singular vitamin are uncommon. However, deficiencies may exist if overall dietary intake is reduced. A mixture of all B vitamins should adequately provide for daily needs. Since most athletes supplement with a multivitamin product, intakes are generally at or above the RDA.;
Vitamin A
Retinoids are a group of compounds of which some have vitamin A activity and others do not. Vitamin A is often referred to as retinol in much of the literature and will be used interchangeably here. Although carotenoids are commonly mistaken for vitamin A, only a fraction of them have any vitamin A activity. b-Carotene is the most significant because in the body it can be broken down into the two retinol molecules and therefore supply vitamin A when needed. Retinol is stored in the liver and distributed to peripheral tissues by strict regulatory mechanisms and metabolized in several pathways (7).
Retinol is converted to retinoic acid inside cells and both are potent regulators of specific genes, including expression of fibronectin and type I procollagen (32,35). Other metabolites of retinol regulate cell differentiation and are associated with glycosaminoglycan (GAG), glycoprotein and proteoglycan (PG) synthesis. Although still unclear, the role of vitamin A in PG synthesis may be involved in sulfation of GAGs. Tissue from animals deficient in vitamin A typically displays decreased synthesis of highly sulfated GAGs (35).
Few in vivo studies exist documenting specific roles of retinoids in connective tissue, except for those studying wound healing in animal models. That rapidly growing tissues are sensitive to vitamin A deficiency is well known. Deficiency of other nutrients, such as zinc and protein, that assist in the transport and metabolism of retinol may induce deficiency symptoms (8). Therefore, since retinol distribution from the liver is tightly regulated, functional deficiencies may result with normal vitamin A intake and stores. Additionally, extra-physiological doses of vitamin A may counteract the inhibitory effects of systemic corticosteroids on plasma retinol transport (32,34).
Because vitamin A is fat-soluble, toxicity is also a concern in connective tissue metabolism. High levels may inhibit collagen synthesis, as seen in the skin, and increase catabolism of cartilage. This may be concentration dependent since excessively high levels affect ascorbate induced lipid peroxidation, which in turn inhibits AA-induced collagen synthesis (35,36).
Vitamin E
Vitamin E is a group of compounds comprising two major classes: tocopherols and tocotrinols. The basic chemical structure in each class is similar with variations of substituents and confirmation resulting in different relative activity. For a complete discussion, please refer to a text on nutrition or medicinal chemistry. The term Vitamin E is used in this article as a reference primarily to the tocopherols, as they have the greatest activity within the body.
Literature information on the role of vitamin E connective tissue metabolism is controversial. The major function of vitamin E is as an antioxidant and in the maintenance of cell membrane integrity. Its role as an antioxidant is thought to require vitamin C and selenium. Although no specific disease of connective tissue can be attributed to vitamin E deficiency, it is no doubt need for life and cell processes.
Animal model studies have shown that severe deficiency in vitamin E influence collagen cross-linking and an increase in susceptibility of insoluble collagen to degradation by proteinases (35). Conversely, excessive doses of vitamin E elicit effects similar to those of corticosteroids: inhibition of collagen synthesis and wound repair. Rats given supra physiological doses of vitamin E exhibited less tensile strength in skin of healed wounds. Indeed, vitamin E may potentiate adverse effects of corticosteroids (34,35).
Vitamin E has exhibited anti-inflammatory effects in some animal models. As an antioxidant, vitamin E may protect lysosome membranes leading to a decrease in histamine and serotonin from mast cells during inflammation. However, studies show that vitamin E has a preventative role rather than therapeutic. If sufficient vitamin E is present before inflammation response is initiated, the inflammatory phase may be shortened. Apparently, therapeutic administration did not affect duration or progress of the inflammation phase (32). Thus perhaps optimal results may be seen in individuals with degenerative joint conditions or with chronic inflammation.
Minerals
Minerals are required for normal cell function and several serve as cofactors in the many enzymatic processes involved in synthesis of connective tissue macromolecules. Copper and manganese are critical cofactors for collagen and GAG synthesis and metabolism. Some recent research alludes to an increased role of manganese in synthesis of GAGs (10). However, a deficiency in these minerals is extremely rare. Some pharmaceuticals are known to negatively interact with some minerals. Nonetheless, defects in collagen synthesis are generally observed only at the lowest levels of dietary intake of most minerals. An athlete eating a diet with adequate protein and calories is like to have normal levels of minerals.
Clinical evidence is largely lacking for effects of mineral deficiencies on connective tissue except for zinc. This mineral primarily acts as a cofactor in many enzyme systems that regulate cell proliferation and growth and in immune integrity. Diminution of collagen synthesis and strength as well as impaired healing is seen in animal tissues with zinc deficiencies.
Controversy exists in whether supplemental zinc can accelerate healing above the normal rate. Several supplement companies in the sports marketing arena claim that most athletes are deficient in this mineral. However, total body assessment of zinc is not easily obtained and many published studies have erroneously relied on data interpretation from zinc plasma concentrations in humans (8,9,11,32). As well, most studies do not measure plasma concentration versus time to assess fluctuations.
Zinc exists in intracellular and extracellular pools and its exchange in the body is tightly regulated (12). Many factors influence tissue pool concentrations, such as absorption, oral contraceptives, and steroid therapy (11). Nonetheless, a well-nourished athlete with a healthy intake of animal protein, fruit, vegetables and a vitamin/mineral supplement is unlikely to be deficient in zinc. Populations who may exhibit deficiencies are the elderly, those with malabsorption, and lactovegetarians who consume large amounts of foods with phytates.
References
1.Carpenter, KJ. Protein and Energy: A study of changing ideas in nutrition. 1994. Cambridge University. Press.
2. Waterlow JC. Metabolic Adaptation to low intakes of energy and protein. Ann Rev Nutr, 1986; 6:495-526.
3. Scrimshaw, NS and Young VR. Adaptation to low protein and energy intakes. Human Org, 1989; 48:20-30.
4. Fay MJ, Bush MJ, Verlangier AJ. Effects of cytochalasin B on uptake of ascorbic acid and glucose by 3T3 fibroblasts: mechanism of impaired ascorbate transport in diabetes. Life Sciences, 1990, 46:619-624.
5. Okuda Y, Magahama M, Mizutani M, et al. Ascorbic acid prevents the inhibition of DNA synthesis induced by high glucose concentration in cultured human endothelial cells. Diabetes Res, 1991; 18:65-68.
6. Russel JE, Manske PR. Ascorbic acid requirement for optimal flexor tendon repair in vitro. J Orthop Res, 1991; 9:714-719.
7. Foye WO, Lemke TL, Williams DA, eds. In: Priciples of Medicinal Chemistry, fourth ed. 1995. Williams and Wilkins pub.
8. Groff JL, Gropper SS, Hunt SM. In: Advanced Nutrition and Human Metabolism, second ed. 1995. West Publishing Co.
9. Dimitrov NV, MacDonald D, Malovrh MM. Bioavailability of Micronutrients in Humans. J Appl Nutr 1997; 49:56-65.
10. Leach RM. Role of Manganese in mucopolysaccharide metabolism. Fed Proc 1971; 30-991.
11. Milne DB. Assessment of zinc and copper nutritional status in man. Nutr MD 1987; 13:1-2.
12. King MT, King JC, Tamura T, et al. Assessment of zinc status. J Nutr 1990; 120:1474-1479.
32. Bucci LR. Nutrition applied to Injury Rehabilitation and Sports Medicine. 1995. Human Kinetics Press.
33. Fisher E, McLennan SV, Tada H, et al. Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts. Diabetes 1991; 40:371-376.
34. Ruberg RL. Role of Nutrition in wound healing. Surg Cl No Am 1984; 4:705-714.
35. Tinker D, Rucker R. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Phys Rev 1985; 65:607-657.
36. Berg RA, Kerr JS. Nutritional aspects of collagen metabolism. Annu Rev Nutr 1992; 369-390.